Immune-System Booster Bests Chemotherapy in Cancer Study

Cancer researchers say a new drug that boosts the body's immune system to attack tumors is less toxic and performs better than traditional chemotherapy in fighting a form of lung cancer. In a study of 582 previously treated patients, Opdivo — one of three U.S.-approved drugs that stimulate the immune system — reduced by 27 percent the risk of death from one form of non-small-cell lung cancer, compared with chemotherapy. It also shrank tumors for nearly 20 percent of those patients,...

Read complete article

~	UN human rights chief welcomes rape law reform in Lebanon, Tunisia, Jordan

~	Justice vital to help Iraqi victims of ISIL's sexual violence rebuild lives – UN report

~	'No sign of positive evolution' in Burundi, says head of independent UN rights probe

~	Following El Salvador visit, UN right expert urges authorities to protect people from gangs

~	UN rights experts warn new EU policy on boat rescues will cause more people to drown

~	'Racism, xenophobia, anti-Semitism or Islamophobia are poisoning our societies' – UN chief

~	UN rights chief urges Kenyan leaders to act responsibly, avoid further violence

~	UN rights office 'deeply concerned' about deteriorating humanitarian conditions in Gaza

~	UN rights expert urges restraint in security operation in Myanmar's Rakhine state

~	Protecting indigenous peoples' rights 'is protecting everyone's rights' – UN